Enterprise-Grade EDC, Without the Enterprise Overhead

Fully validated and audit-ready

Trusted across 10K+ studies in 30+ countries

No-code configuration, no programmers required

20 years of clinical rigor. Predictable pricing. No six-figure implementation.

See how easy Medrio is to set up and run with a demo

SurveyRight vs. DIY Tools

VALIDATED CONTENT

GENERIC FORMS

THIRD-PARTY CANDOR

INTERNAL BIAS CONCERNS

DRIVER-RANKED PRIORITIES

ISOLATED SCORES

BENCHMARKS & TREND VIEWS

STATIC RESULTS

MANAGED DELIVERY

HEAVY INTERNAL LIFT

Frequently asked questions

FAQ Accordion
1 How does Medrio compare to legacy enterprise EDCs like Medidata or Oracle?
×
Legacy systems often require six to twelve months for implementation and specialized programming teams. Medrio removes the enterprise overhead, allowing you to go from protocol to live in two to three weeks using a no-code, drag-and-drop interface that requires zero programmer support.
2 Why choose Medrio over an inflated platform like Veeva Vault?
+
While Veeva offers a broad suite of tools, it often comes with significant complexity and a services-heavy model where you are dependent on the vendor for builds. Medrio offers a natively unified platform including EDC, ePRO, RTSM, and eTMF, but prioritizes direct control. This gives your team the power to manage the system internally without waiting in vendor queues.
3 What makes Medrio more inspection-ready than Castor or REDCap?
+
Lightweight or academic tools like REDCap and Castor may have limited compliance documentation, insubstantial in-house resources, or insufficient scalability to handle complex global studies. Medrio bridges the gap by offering the rigor of enterprise-grade audit trails and data integrity while keeping the user interface modern and intuitive enough for a single-site study.
4 How does Medrio outperform Viedoc and newer EDC entrants?
+
While many newer providers have modern interfaces, Medrio leads in efficiency during the mid-study phase. Medrio users report 83% faster mid-study changes and 65% faster database locks than traditional systems, ensuring your trial stays on schedule even when protocols change. Medrio is also significantly more proven than these newer EDC entrants, having supported hundreds of approvals and more than 10,000 studies across 20+ years of experience.
5 We are using spreadsheets and PDFs, so why pay for Medrio?
+
Manual workflows have a low barrier to entry but carry high risks regarding data integrity and version control. As your study scales, the lack of a validated audit trail can lead to failed inspections or delayed submissions. Medrio automates compliance and reduces site burden, providing a total cost of ownership that is significantly lower than the cost of a compromised trial.
6 Does Medrio require the same level of IT support as legacy systems?
+
No. Medrio is a guided platform. Unlike Medidata or Oracle, which often require dedicated SQL or C# programmers, Medrio's point-and-click interface allows clinical researchers to build and adjust their own databases. This eliminates the need for a large internal IT department or expensive external consultants for every study build.
7 How does Medrio's support compare to enterprise vendors?
+
Legacy enterprise vendors often price technical support, training, and certifications separately. Medrio's subscription pricing is all-inclusive, providing 24/7 global support and full training access without the hidden fees common with legacy providers.
8 Is the learning curve for sites moving from Medidata or Veeva to Medrio difficult?
+
Most site coordinators find Medrio more intuitive. Because it requires up to 50% fewer clicks for data entry and no specialized programming for database setup, site coordinators and data managers are usually fully proficient in days rather than weeks.
9 Can Medrio handle the same complexity as the big three legacy vendors?
+
Yes. While Medrio is known for speed, it is trusted for complex, multi-phase global programs. It meets the same 21 CFR Part 11 and global regulatory requirements as legacy providers but achieves it through a more flexible, modern architecture.
10 Why is Medrio the right fit for scaling life sciences teams?
+
Scaling teams often outgrow lightweight tools but are not ready for the complexity of an enterprise mandate. Medrio provides enterprise-grade power with a low-overhead implementation, allowing you to maintain direct control over your data as you move from Phase 1 into large-scale trials without switching platforms.

POWERING TRIALS FOR EMERGING INNOVATORS 

Get power and flexibility with the EDC built just for you

See Medrio in action with a free live demo.

Is Medrio the right EDC for you?

Most EDC decisions come down to four things: how fast you can get a study live, how much control your team has over the data, whether you can stand behind it in an audit, and what you're actually paying.

Upholding the highest compliance standards

How the main EDC options compare

Medrio

Built for small and scaling life sciences teams

  • Validated and audit-ready

  • Single platform from Phase I to post-market, and everything in between

  • 83% faster mid-study changes

  • 65% faster database lock 

  • Flexible no-code control 

  • Subscription pricing with no added costs for support, training, or certifications

  • Unified platform with CTMS, eConsent, ePRO, eTMF and RTSM solutions

Spreadsheets, PDFs

 Manual workflows

  • Low barrier to entry

  • No software costs

  • Familiar to most teams

Pros:

Cons:

  • No audit trail or inspection readines

  • Data errors are easy to introduce and hard to catch

  • Doesn't scale beyond very small, low-risk studies

Castor, REDCap, Viedoc

Newer, lightweight EDC providers

Medidata, Veeva, Oracle

Legacy Enterprise EDC providers

Pros:

  • Lower upfront cost

  • Modern interfaces

  • Built for academic research or simple, single-site studies

Cons:

  • Limited compliance documentation

  • Limited data export functionality 

  • Support depth varies significantly

  • Not scalable across different phases and study types
  • Mandated standard across many large enterprise pharma organizations

  • Meets requirements for highly complex, multi-phase global programs

Pros:

  • Additional users, seats, support, training, and certifications priced separately

  • Implementation timelines run 6 to 12 months

  • Support depth varies significantly

Cons:

Copyright 2026 Medrio, All Rights Reserved. Privacy Policy

Schedule demoSchedule demo
Schedule demo